Compounds > gaboxadol
Page last updated: 2024-10-27

gaboxadol and Akinetic-Rigid Variant of Huntington Disease

gaboxadol has been researched along with Akinetic-Rigid Variant of Huntington Disease in 3 studies

gaboxadol: GABA agonist; inhibitor of GABA uptake systems; structure

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wójtowicz, AM1
Dvorzhak, A1
Semtner, M1
Grantyn, R1
Foster, NL1
Chase, TN1
Denaro, A1
Hare, TA1
Tamminga, CA1
Waddington, JL1
Cross, AJ1

Trials

1 trial available for gaboxadol and Akinetic-Rigid Variant of Huntington Disease

ArticleYear
THIP treatment of Huntington's disease.
    Neurology, 1983, Volume: 33, Issue:5

    Topics: Adult; Clinical Trials as Topic; Disability Evaluation; Double-Blind Method; Female; Homovanillic Ac

1983

Other Studies

2 other studies available for gaboxadol and Akinetic-Rigid Variant of Huntington Disease

ArticleYear
Reduced tonic inhibition in striatal output neurons from Huntington mice due to loss of astrocytic GABA release through GAT-3.
    Frontiers in neural circuits, 2013, Volume: 7

    Topics: Animals; Anisoles; Astrocytes; Corpus Striatum; GABA Agonists; GABA Plasma Membrane Transport Protei

2013
Therapeutic failure of GABA agonist treatment in Huntington's disease.
    Neurology, 1984, Volume: 34, Issue:5

    Topics: gamma-Aminobutyric Acid; Humans; Huntington Disease; Isoxazoles; Oxazoles

1984